Safety and efficacy of pembrolizumab monotherapy in patients with previously treated advanced gastric and gastroesophageal junction cancer: Phase 2 clinical KEYNOTE-059 trial

Thumbnail Image
Files
Safety and efficacy of pembrolizumab monotherapy in patients with previously treated advanced gastric and gastroesophageal junction cancer Phase 2 clinical KEYNOTE-059 trial.pdf(3.64 KB)
Date
2018
Authors
Show 1 more
Journal Title
Journal ISSN
Volume Title
Publisher
Abstract
Description
Keywords
Citation
URI
https://doi.org/10.1001/jamaoncol.2018.0013
 https://repositorio.uc.cl/handle/11534/60038
Collections
Artículos de revistas